Skip to main content
. 2018 May 14;7:e32919. doi: 10.7554/eLife.32919

Figure 7. Co-culture of NK cells with RAE-1δ-expressing macrophages and tumor cells.

(A) Peritoneal macrophages from WT or RAE-1-KO mice or were stimulated with 10 ng/ml CSF-1 for 48 hr and then co-cultured with WT splenocytes for 18 hr, and NKG2D levels were analyzed by flow cytometry. (B) B16 or B16-RAE-1δ cells were co-cultured with WT splenocytes for 18 hr, and NKG2D levels on NK cells were analyzed by flow cytometry. (C) WT splenocytes were co-cultured with CSF-1-stimulated WT or RAE-1-KO macrophages for 18 hr, followed by 5 hr stimulation with plate-bound antibody against the NK cell activating receptor NKp46, or control Ig, and NK cell IFNγ and degranulation were analyzed by flow cytometry. (D) WT splenocytes were co-cultured with B16 or B16-RAE-1δ cells for 18 hr, followed by 5 hr stimulation with plate-bound antibody against the NK cell activating receptor NKp46, and NK cell IFNγ and degranulation were analyzed by flow cytometry.

Figure 7.

Figure 7—figure supplement 1. Tumor associated macrophage numbers and RAE-1δ expression in RAE-1-KO and NKG2D-KO mice.

Figure 7—figure supplement 1.

(A) TAMs as a percentage of CD45 + cells in established B16 tumors in WT and RAE-1-KO mice. (B) RAE-1δ on TAMs in B16 tumors in WT and NKG2D-KO mice.